[1]
Wulandari, L. and Wiriansya, E.P. 2017. COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON NSLCLC PATIENTS WITH DISEASE PROGRESSION AND EGFR-TKI TREATMENT. Folia Medica Indonesiana. 53, 4 (Dec. 2017), 276–282. DOI:https://doi.org/10.20473/fmi.v53i4.7161.